291 related articles for article (PubMed ID: 17826792)
1. Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein.
Kelly BN; Kyere S; Kinde I; Tang C; Howard BR; Robinson H; Sundquist WI; Summers MF; Hill CP
J Mol Biol; 2007 Oct; 373(2):355-66. PubMed ID: 17826792
[TBL] [Abstract][Full Text] [Related]
2. Antiviral inhibition of the HIV-1 capsid protein.
Tang C; Loeliger E; Kinde I; Kyere S; Mayo K; Barklis E; Sun Y; Huang M; Summers MF
J Mol Biol; 2003 Apr; 327(5):1013-20. PubMed ID: 12662926
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation.
Novikova M; Adams LJ; Fontana J; Gres AT; Balasubramaniam M; Winkler DC; Kudchodkar SB; Soheilian F; Sarafianos SG; Steven AC; Freed EO
mBio; 2018 Oct; 9(5):. PubMed ID: 30327442
[TBL] [Abstract][Full Text] [Related]
4. Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein.
Lemke CT; Titolo S; von Schwedler U; Goudreau N; Mercier JF; Wardrop E; Faucher AM; Coulombe R; Banik SS; Fader L; Gagnon A; Kawai SH; Rancourt J; Tremblay M; Yoakim C; Simoneau B; Archambault J; Sundquist WI; Mason SW
J Virol; 2012 Jun; 86(12):6643-55. PubMed ID: 22496222
[TBL] [Abstract][Full Text] [Related]
5. Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography.
Goudreau N; Lemke CT; Faucher AM; Grand-Maître C; Goulet S; Lacoste JE; Rancourt J; Malenfant E; Mercier JF; Titolo S; Mason SW
ACS Chem Biol; 2013 May; 8(5):1074-82. PubMed ID: 23496828
[TBL] [Abstract][Full Text] [Related]
6. [The role of structural protein Gag and related gene (protein) in late stages of the HIV-1 replication cycle and the inhibitors].
Jiang Y; Liu XY
Yao Xue Xue Bao; 2010 Feb; 45(2):205-14. PubMed ID: 21351430
[TBL] [Abstract][Full Text] [Related]
7. Effects of an HIV-1 maturation inhibitor on the structure and dynamics of CA-SP1 junction helices in virus-like particles.
Gupta S; Louis JM; Tycko R
Proc Natl Acad Sci U S A; 2020 May; 117(19):10286-10293. PubMed ID: 32341150
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain.
Zhang H; Curreli F; Zhang X; Bhattacharya S; Waheed AA; Cooper A; Cowburn D; Freed EO; Debnath AK
Retrovirology; 2011 May; 8():28. PubMed ID: 21539734
[TBL] [Abstract][Full Text] [Related]
9. Structure of the HIV-1 full-length capsid protein in a conformationally trapped unassembled state induced by small-molecule binding.
Du S; Betts L; Yang R; Shi H; Concel J; Ahn J; Aiken C; Zhang P; Yeh JI
J Mol Biol; 2011 Feb; 406(3):371-86. PubMed ID: 21146540
[TBL] [Abstract][Full Text] [Related]
10. A cell-penetrating helical peptide as a potential HIV-1 inhibitor.
Zhang H; Zhao Q; Bhattacharya S; Waheed AA; Tong X; Hong A; Heck S; Curreli F; Goger M; Cowburn D; Freed EO; Debnath AK
J Mol Biol; 2008 May; 378(3):565-80. PubMed ID: 18374356
[TBL] [Abstract][Full Text] [Related]
11. The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly.
Neira JL
FEBS J; 2009 Nov; 276(21):6110-7. PubMed ID: 19825045
[TBL] [Abstract][Full Text] [Related]
12. Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors.
Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Zheng YT; Luo H
Int J Antimicrob Agents; 2020 Apr; 55(4):105926. PubMed ID: 32092396
[TBL] [Abstract][Full Text] [Related]
13. Residues in the HIV-1 capsid assembly inhibitor binding site are essential for maintaining the assembly-competent quaternary structure of the capsid protein.
Bartonova V; Igonet S; Sticht J; Glass B; Habermann A; Vaney MC; Sehr P; Lewis J; Rey FA; Kraüsslich HG
J Biol Chem; 2008 Nov; 283(46):32024-33. PubMed ID: 18772135
[TBL] [Abstract][Full Text] [Related]
14. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
Shi J; Zhou J; Shah VB; Aiken C; Whitby K
J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083
[TBL] [Abstract][Full Text] [Related]
15. Maturation inhibitors facilitate virus assembly and release of HIV-1 capsid P224 mutant.
Timilsina U; Ghimire D; Adhikari LP; Bhattarai A; Mishra N; Rai M; Dubey RC; Gaur R
Virology; 2018 Aug; 521():44-50. PubMed ID: 29879541
[TBL] [Abstract][Full Text] [Related]
16. Resistance to Second-Generation HIV-1 Maturation Inhibitors.
Urano E; Timilsina U; Kaplan JA; Ablan S; Ghimire D; Pham P; Kuruppu N; Mandt R; Durell SR; Nitz TJ; Martin DE; Wild CT; Gaur R; Freed EO
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567982
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of HIV-1 capsid protein assembly inhibitor (CAP-1) and its analogues based on a biomass approach.
Romashov LV; Ananikov VP
Org Biomol Chem; 2016 Dec; 14(45):10593-10598. PubMed ID: 27714265
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein.
Nangola S; Urvoas A; Valerio-Lepiniec M; Khamaikawin W; Sakkhachornphop S; Hong SS; Boulanger P; Minard P; Tayapiwatana C
Retrovirology; 2012 Feb; 9():17. PubMed ID: 22348230
[TBL] [Abstract][Full Text] [Related]
19. Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: structure-activity relationships (SAR) of the C3-phenyl moiety.
Fader LD; Landry S; Goulet S; Morin S; Kawai SH; Bousquet Y; Dion I; Hucke O; Goudreau N; Lemke CT; Rancourt J; Bonneau P; Titolo S; Amad M; Garneau M; Duan J; Mason S; Simoneau B
Bioorg Med Chem Lett; 2013 Jun; 23(11):3401-5. PubMed ID: 23601710
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
J Virol; 2017 May; 91(9):. PubMed ID: 28202766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]